Physician Advocacy for Hematopoietic Cell Transplantation and Cell Therapy: Overcoming Challenges to Reduce Disparities and Improve Outcomes for Patients
Nima Ghalehsari(Moffitt Cancer Center), Alexandra Gomez-Arteaga(Cornell University), Stella M. Davies(Cincinnati Children's Hospital Medical Center), Alycia Maloney, Jennifer Holter‐Chakrabarty(University of Oklahoma Health Sciences Center), Kristie N. Ramos(Cincinnati Children's Hospital Medical Center), María A. Pereda(Children's Hospital of New Orleans), Manuel Espinoza‐Gutarra(University of Alabama at Birmingham), Dianna S. Howard(Atrium Health Wake Forest Baptist), Jeffery J. Auletta(Nationwide Children's Hospital), Anurekha G. Hall(Seattle Children's Hospital), Manu Pandey(Oklahoma State University Oklahoma City), Ellie Beaver(National Marrow Donor Program), Rahul Shah(The University of Texas MD Anderson Cancer Center), Jess Knutson(National Marrow Donor Program), Ellen Fraint(Memorial Sloan Kettering Cancer Center)
Cited by 1
Related Papers
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
|Nature Medicine|2018|577
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554
Recommended Screening and Preventive Practices for Long-Term Survivors after Hematopoietic Cell Transplantation
|Biology of Blood and Marrow Transplantation|2011|363
COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients
|Journal of Infection|2021|248
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy
|Transplantation and Cellular Therapy|2021|183